Overview

Efficacy and Safety of Dexmedetomidine During Weaning From Analgesia and Sedation in PICU (TIP-15-01)

Status:
Terminated
Trial end date:
2020-01-18
Target enrollment:
Participant gender:
Summary
This interventional study evaluates the efficacy of dexmedetomidine during weaning from analgesic and sedative drugs in reducing the occurrence of the withdrawal syndrome in PICU. All enrolled patients will undergo the same weaning regimen one half will receive dexmedetomidine while the other will receive a placebo.
Phase:
Phase 2
Details
Lead Sponsor:
Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Collaborators:
Azienda Ospedaliera di Padova
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Policlinico Universitario Agostino Gemelli
Treatments:
Dexmedetomidine
Pharmaceutical Solutions